专利检索 ap:"DS Biopharma Limited" 第 1 页

1.

发明授权
Pharmaceutical compositions comprising DGLA and use of same 有权

公开(公告)号：US11478442B2

公开(公告)日：2022-10-25

申请号：US16910770

申请日：2020-06-24

申请人： DS Biopharma Limited

发明人： Mehar Manku , John Climax , David Coughlan , James Dunne

IPC分类号： A61K31/202 , A61K9/48 , A61K9/00 , A61P17/00 , A61Q19/00 , A61K8/11 , A61K8/65 , A61K8/36 , A61K31/201 , A61P17/04

摘要： The present disclosure provides orally deliverable pharmaceutical compositions comprising DGLA and to methods of using same to treat a variety of conditions and disorders.

2.

发明申请
Compositions Comprising Oxo-Derivatives of Fatty Acids and Methods of Making and Using Same 有权

公开(公告)号：US20220324788A1

公开(公告)日：2022-10-13

申请号：US17527440

申请日：2021-11-16

申请人： DS Biopharma Limited

发明人： Mehar Manku , John Climax , David Coughlan

IPC分类号： C07C59/76 , A61K45/06 , A61K31/202 , A61K31/232

摘要： The present disclosure provides 15-oxo-EPA and 15-oxo-DGLA, compositions comprising 15-oxo-EPA and/or 15-oxo-DGLA, and methods of treating and/or preventing fibrosis, skin disorders, inflammation, kidney disease or renal dysfunction in a subject in need thereof by administering 15-oxo-EPA and/or 15-oxo-DGLA.

3.

发明授权
Topical compositions comprising polyunsaturated fatty acids 有权

公开(公告)号：US10918614B2

公开(公告)日：2021-02-16

申请号：US16450187

申请日：2019-06-24

申请人： DS Biopharma Limited

发明人： Adam Kelliher , Angus Morrison , Phil Knowles

IPC分类号： A61K31/202 , A61K31/573 , A61K45/06 , C07C59/42 , A61K9/00

摘要： The present invention provides a compound which is a polyunsaturated fatty acid (PUFA) derivative of formula (I), or a pharmaceutically acceptable salt, or solvate thereof, for use in treating various skin disorders.

4.

发明申请
TOPICAL COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACIDS 审中-公开

公开(公告)号：US20190314317A1

公开(公告)日：2019-10-17

申请号：US16450187

申请日：2019-06-24

申请人： DS Biopharma Limited

发明人： Adam Kelliher , Angus Morrison , Phil Knowles

IPC分类号： A61K31/202 , C07C59/42 , A61K31/573 , A61K45/06 , A61K9/00

摘要： The present invention provides a compound which is a polyunsaturated fatty acid (PUFA) derivative of formula (I), or a pharmaceutically acceptable salt, or solvate thereof, for use in treating various skin disorders.

5.

发明申请
PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND USE OF SAME 审中-公开

公开(公告)号：US20180036272A1

公开(公告)日：2018-02-08

申请号：US15661374

申请日：2017-07-27

申请人： DS Biopharma Limited

发明人： Mehar Manku , John Climax , David Coughlan , James Dunne

IPC分类号： A61K31/202 , A61K8/65 , A61K8/11 , A61K9/00 , A61K8/36 , A61K9/48 , A61Q19/00

CPC分类号： A61K31/202 , A61K8/11 , A61K8/361 , A61K8/65 , A61K9/0053 , A61K9/48 , A61K9/4825 , A61Q19/00

摘要： The present disclosure provides orally deliverable pharmaceutical compositions comprising DGLA and to methods of using same to treat a variety of conditions and disorders.

6.

发明申请
METHODS OF TREATING INFLAMMATORY, FIBROTIC, AND PROLIFERATIVE CONDITIONS USING COMPOSITIONS COMPRISING DGLA AND/OR 15-HETRE, AND ASSOCIATED METHODS AND COMPOSITIONS 有权

公开(公告)号：US20210322354A1

公开(公告)日：2021-10-21

申请号：US17106348

申请日：2020-11-30

申请人： DS Biopharma Limited

发明人： John Climax , David Coughlan , Markus Weissbach , Moayed Hamza

IPC分类号： A61K31/202 , A61P17/00 , A61P37/06

摘要： The present disclosure provides orally and/or topically deliverable pharmaceutical compositions comprising DGLA or a derivative thereof and/or 15-HETrE or a derivative thereof and methods of using same to treat a variety of conditions, diseases, and disorders, including but not limited to inflammatory, fibrotic, and proliferative conditions, diseases, and disorders.

7.

发明申请
PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND USE OF SAME 审中-公开

公开(公告)号：US20200323807A1

公开(公告)日：2020-10-15

申请号：US16910770

申请日：2020-06-24

申请人： DS Biopharma Limited

发明人： Mehar Manku , John Climax , David Coughlan , James Dunne

IPC分类号： A61K31/202 , A61K9/48 , A61K9/00 , A61Q19/00 , A61K8/11 , A61K8/65 , A61K8/36 , A61P17/00 , A61K31/201 , A61P17/04

摘要： The present disclosure provides orally deliverable pharmaceutical compositions comprising DGLA and to methods of using same to treat a variety of conditions and disorders.

8.

发明授权
Compositions comprising oxo-derivatives of fatty acids and methods of making and using same 有权

公开(公告)号：US10570083B2

公开(公告)日：2020-02-25

申请号：US15921211

申请日：2018-03-14

申请人： DS Biopharma Limited

发明人： Mehar Manku , John Climax , David Coughlan

IPC分类号： A61K31/202 , A61K31/232 , C07C59/76 , A61K45/06

摘要： The present disclosure provides 15-oxo-EPA and 15-oxo-DGLA, compositions comprising 15-oxo-EPA and/or 15-oxo-DGLA, and methods of treating and/or preventing fibrosis, skin disorders, inflammation, kidney disease or renal dysfunction in a subject in need thereof by administering 15-oxo-EPA and/or 15-oxo-DGLA.

9.

发明申请
PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND USE OF SAME 审中-公开

公开(公告)号：US20190269639A1

公开(公告)日：2019-09-05

申请号：US16279794

申请日：2019-02-19

申请人： DS Biopharma Limited

发明人： Mehar Manku , John Climax , David Coughlan , James Dunne

IPC分类号： A61K31/201 , A61K9/48 , A61K9/00 , A61P17/00

摘要： The present disclosure provides orally deliverable pharmaceutical compositions comprising DGLA and to methods of using same to treat a variety of conditions and disorders.

10.

发明授权
Topical compositions comprising polyunsaturated fatty acids 有权

公开(公告)号：US10328046B2

公开(公告)日：2019-06-25

申请号：US15856254

申请日：2017-12-28

申请人： DS Biopharma Limited

发明人： Adam Kelliher , Angus Morrison , Phil Knowles

IPC分类号： A61K9/00 , A61K45/06 , A61K31/202 , A61K31/573

摘要： The present invention provides a compound which is a polyunsaturated fatty acid (PUFA) derivative of formula (I), or a pharmaceutically acceptable salt, or solvate thereof, for use in treating various skin disorders.